Lantern Pharma, a clinical stage biotechnology company focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from its targeted oncology therapies, announced today that it surpassed the milestone of 450 million curated data points being utilized in its proprietary A.I. and machine learning-powered platform, RADR® (Response Algorithm for Drug Positioning and...
GLOBENEWSWIRE
READ MORE
|
A biotech company using artificial intelligence (AI) for drug discovery, and the Drugs for Neglected Diseases initiative (DND i ), a not-for-profit research and development organization working to deliver new treatments for neglected diseases, today announced that promising drug-like compounds have been discovered in a program to develop first-in-class treatments for Chagas disease. The research collaboration is part of Atomwise’s Artificial Intelligence Molecular Screen (AIMS) Awards prog...
ATOMWISE, INC.
READ MORE
|
Shares of Orchard Therapeutics are climbing this morning after the company announced positive results from a two-year follow up of the company’s stem cell gene therapy for the treatment of severe combined immune deficiency due to adenosine deaminase deficiency (ADA-SCID). This morning the London-based company announced the follow-up data from its registrational trial of OTL-101, an ex vivo, autologous, gene therapy candidate. The trial hit its primary endpoints, Orchard said. The company s...
READ MORE
|
Researchers have identified that certain drugs taken in combination, ‘drug cocktails’, help therapies to target and attack cancer more efficiently. The team from Mount Sinai School of Medicine discovered that side effects lessened when using certain ‘drug cocktails’. The combination of drugs attacks cancer cells from multiple angles, preventing cell growth and proliferation, and cancer’s ability to become resistant to individual drugs. The combinations of drugs test...
READ MORE
|
According to the World Health Organization, a competitive market place is the best way to ensure low prices for drugs. Proper organization of the market and application of anti-trust (monopoly) laws should facilitate price competition. However, in some cases, if pharmaceutical markets do not become competitive, control or regulation of medicines prices may be based on actual cost, controlling company’s profit margins, or comparison with prices of other medicines in the same therapeutic categorie...
GUARDIAN.NG
READ MORE
|
The modular components provide scientists with excellent process control, and the ability to choose from a range of particle diameters between 10 and 50 µm on a single piece of hardware. PLGA, or poly(lactic-co-glycolic acid), is a copolymer commonly used for drug microencapsulation. Precise manipulation of particle size, shape and architecture is extremely important to the efficacy of the candidate drug....
READ MORE
|